CTDH Insider Trading Activity and SEC Form 4 Filings
CTDH insider trading summary
No open-market insider purchases or sales of Cyclo Therapeutics, Inc. (CTDH) have been reported on SEC Form 4 in the past 12 months.
Latest CTDH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 25, 2020 | Joshua M Fine | Chief Financial Officer | Buy | $1K (15,000 @ $0.07) |
| Nov 23, 2020 | Joshua M Fine | Chief Financial Officer | Buy | $799 (10,000 @ $0.08) |
| Sep 30, 2020 | Armistice Capital Master Fund Ltd. | 10% Owner | Sell | $0 (0 @ $0.00) |
| Sep 30, 2020 | Armistice Capital, LLC | 10% Owner | Sell | $0 (0 @ $0.00) |
| Sep 30, 2020 | Armistice Capital Master Fund Ltd. | 10% Owner | Sell | $715 (5,500 @ $0.13) |
| Sep 30, 2020 | Steven Boyd | 10% Owner | Sell | $0 (0 @ $0.00) |
| Sep 30, 2020 | Steven Boyd | 10% Owner | Sell | $715 (5,500 @ $0.13) |
| Sep 30, 2020 | Armistice Capital, LLC | 10% Owner | Sell | $715 (5,500 @ $0.13) |
| Sep 29, 2020 | Armistice Capital, LLC | 10% Owner | Sell | $0 (0 @ $0.00) |
| Sep 29, 2020 | Armistice Capital, LLC | 10% Owner | Sell | $700 (5,000 @ $0.14) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.